Phase 1 trial
First-in-human study. Small sample (20-80 volunteers), focused on safety, tolerability, and pharmacokinetics. Not powered for efficacy.
First-in-human study. Small sample (20-80 volunteers), focused on safety, tolerability, and pharmacokinetics. Not powered for efficacy.